Gilead soars 11% after reporting positive news on potential coronavirus treatment (GILD)

Gilead soars 11% after reporting positive news on potential coronavirus treatment (GILD)

Business Insider

Published

**

· *Gilead on Wednesday said that remdesivir, its leading coronavirus treatment, succeeded in a critical trial. *
· *Shares surged as much as 11% on the news, and led US stocks higher in premarket trading. *
· *Watch Gilead trade live on Markets Insider. *
· *Read more on Business Insider. *

...

Full Article